|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-10-28
|
|
pubmed:abstractText |
The rapid pace of the development and introduction to the marketplace of new medical technologies has been identified as one of the primary drivers of the increasing cost of health care delivery in the United States. The purpose of this study is to evaluate the role of the wide divergence of interests of the various stakeholders in contributing to the increasing cost of care.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1558-349X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1125-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18954812-Biomedical Technology,
pubmed-meshheading:18954812-Endpoint Determination,
pubmed-meshheading:18954812-Health Care Costs,
pubmed-meshheading:18954812-Health Expenditures,
pubmed-meshheading:18954812-Health Policy,
pubmed-meshheading:18954812-Health Services Accessibility,
pubmed-meshheading:18954812-Humans,
pubmed-meshheading:18954812-Policy Making,
pubmed-meshheading:18954812-Risk Factors,
pubmed-meshheading:18954812-Technology, High-Cost,
pubmed-meshheading:18954812-Technology Assessment, Biomedical,
pubmed-meshheading:18954812-United States,
pubmed-meshheading:18954812-United States Food and Drug Administration
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
|
|
pubmed:affiliation |
21st Century Oncology, Inc., Fort Myers, Florida, USA. pwallner@rtsx.com
|
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|
